AI-Designed Vaccine Enters Human Trials for Universal Virus Protection

The Shift from Reactive to Proactive Vaccine Design

Researchers at the University of Cambridge have successfully moved a vaccine candidate into human trials, marking the first time a vaccine’s core component has been entirely designed by artificial intelligence. This project aims to create broad protection against entire families of viruses, including those with pandemic potential, by using machine learning to engineer a “super … Read more